Article
Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response
2021-04-15
Abstract excerpt
With the continued promise of immunotherapy as an avenue for treating cancer, understanding how host genetics contributes to the tumor immune microenvironment (TIME) is essential to tailoring cancer screening and treatment strategies. Approaches that intersect SNP modifiers of molecular phenotype, such as gene expression, with disease phenotypes have shown promise for implicating causal genetic factors. Here we ev...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- bc712d20-8b01-5241-b34b-d9e2ada35869
- DOI
- 10.1101/2021.04.14.436660
